AI MARKET SCANNING

Invivyd Inc

🏛️ NASDAQ 📁 Health Technology 🏭 Biotechnology
AVG HISTORICAL GAP -2.58%
MAX GAP RECORD -16.27%
🔒 PRO INSTITUTIONAL AI PREDICTIVE WIN RATE
94.2%
REVEAL PRO DIRECTION ⚡

SENTINEL HISTORICAL GAP VIEWER

// $IVVD
📊 1-YEAR TIMELINE (GAPS PLOTTED) 🔮 SIMULATE SETUP 🔒
Bullish Opening Gap Bearish Opening Gap T-1 Close Baseline

CATALYSTS & GAP HISTORY

Aug 13, 2026 Earnings Release 2026-08-13 (BEFORE OPEN)
-3.69%
May 13, 2026 Earnings Release 2026-05-13 (AFTER CLOSE)
-10.20%
Nov 06, 2025 Earnings Release 2025-11-06 (UNDETERMINED)
+0.00%
Aug 14, 2025 Earnings Release 2025-08-14 (AFTER CLOSE)
-10.26%
May 15, 2025 Earnings Release 2025-05-15 (BEFORE OPEN)
-16.27%
Mar 20, 2025 Earnings Release 2025-03-20 (AFTER CLOSE)
+3.25%
Nov 14, 2024 Earnings Release 2024-11-14 (AFTER CLOSE)
+3.67%
Aug 14, 2024 Earnings Release 2024-08-14 (AFTER CLOSE)
+0.00%

VOLATILITY & GAP BIAS

AVG GAP MOVE 6.2%
Bullish Gaps (5)
Bearish Gaps (5)
Neutral / Flat (0)

QUANTITATIVE LIVE RADAR BLOTTER

Algorithmic execution stream for $IVVD

EXECUTIONS0 LOGS
STATUS🔒 ENCRYPTED
Execution Date Strategy & Setup Direction Execution Range Hold Time Net PnL
Radar monitoring: awaiting next setup.
🔒 Real-Time Strategy Telemetry Protected

Exact execution levels, Trailing Stops, and live bot signals are reserved for PRO members.

UNLOCK LIVE RADAR ⚡

📖 Intelligence Summary

Invivyd, Inc. engages in the discovery, development and commercialization of antibody-based solutions for infectious diseases with pandemic potential. The firm develops antibodies that can neutralize SARS-CoV-2, SARS-CoV-1, and additional emergent coronaviruses. It offers ADG20, a monoclonal antibody, targeting the spike protein of SARS-CoV-2 and related coronaviruses. The company was founded…

NEXT UPCOMING PREDICTIVE SIGNAL
STRONG BUY / TARGET +35%
🔓 REVEAL AI SIGNAL & TARGETS ↗